ArticleJournal of neurotrauma2011

Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact.

Alicia A Swan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.